SCHEMBL742397

SCHEMBL742397

Cc1ccc(C2C(C(=O)c3cccs3)=C(O)C(=O)N2CCCN2CCOCC2)o1

nearest known ligand 0.91

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.91
KDM4E B2RXH2 4/20 0.91
ALOX15 P16050 3/20 0.91
KMT2A Q03164 6/20 0.68
MEN1 O00255 5/20 0.68
HTT P42858 3/20 0.68
LMNA P02545 1/20 0.68
MAPK1 P28482 1/20 0.66
MAPT P10636 4/20 0.61
CYP2C19 P33261 2/20 0.61
CASP1 P29466 1/20 0.61
CASP7 P55210 1/20 0.61
TSHR P16473 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.52
PPARG P37231 1/20 0.50
NCOR2 Q9Y618 1/20 0.50
RXFP1 Q9HBX9 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1893374 0.75 KMT2A (0.80) ALDH1A1KDM4EALOX15KMT2AMEN1
SCHEMBL20943505 0.69 PPARG (0.56) ALDH1A1KDM4EALOX15KMT2AMEN1
SCHEMBL15835224 0.69 MAPT (0.58) ALDH1A1KDM4EALOX15KMT2AMEN1
SCHEMBL30774052 0.68 RXFP1 (0.82) ALDH1A1KDM4EALOX15KMT2AMEN1
SCHEMBL1897337 0.68 MEN1 (0.69) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL12668752 0.67 PPARG (0.57) ALDH1A1KDM4EALOX15KMT2AMEN1
SCHEMBL30774054 0.66 MEN1 (0.68) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL1898032 0.66 MEN1 (0.68) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL1896713 0.66 RXFP1 (0.70) ALDH1A1KDM4EALOX15KMT2AMEN1
SCHEMBL30774082 0.66 RXFP1 (0.70) ALDH1A1KDM4EALOX15KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138356-B2 Chemical inhibitors of inhibitors of differentiation Angiogeney, Inc. (US) 2012-03-20 US disclosed
US-20090226422-A1 Chemical Inhibitors of Inhibitors of Differentiation ANGIOGENEX 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090226422-A1 Chemical Inhibitors of Inhibitors of Differentiation BRAF, MAPK1, RAF1 ALDH1A1 1860/4885KDM4E 1876/4885ALOX15 852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.